177 related articles for article (PubMed ID: 21371637)
1. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.
Sørensen R; Abildstrøm SZ; Hansen PR; Hvelplund A; Andersson C; Charlot M; Fosbøl EL; Køber L; Madsen JK; Gislason GH; Torp-Pedersen C
J Am Coll Cardiol; 2011 Mar; 57(10):1202-9. PubMed ID: 21371637
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study.
Charlot M; Nielsen LH; Lindhardsen J; Ahlehoff O; Olsen AM; Hansen ML; Hansen PR; Madsen JK; Køber L; Gislason GH; Torp-Pedersen C
Eur Heart J; 2012 Oct; 33(20):2527-34. PubMed ID: 22798561
[TBL] [Abstract][Full Text] [Related]
3. Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.
Bonde L; Sorensen R; Fosbøl EL; Abildstrøm SZ; Hansen PR; Kober L; Schramm TK; Bretler DM; Weeke P; Olesen J; Torp-Pedersen C; Gislason GH
J Am Coll Cardiol; 2010 Mar; 55(13):1300-7. PubMed ID: 20338489
[TBL] [Abstract][Full Text] [Related]
4. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
[TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
6. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
Shennib H; Endo M; Benhameid O
Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
[TBL] [Abstract][Full Text] [Related]
8. Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Koul S; Smith JG; Scherstén F; James S; Lagerqvist B; Erlinge D
Eur Heart J; 2011 Dec; 32(23):2989-97. PubMed ID: 21719452
[TBL] [Abstract][Full Text] [Related]
9. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
10. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
[TBL] [Abstract][Full Text] [Related]
11. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
14. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
[TBL] [Abstract][Full Text] [Related]
15. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction.
Solomon MD; Go AS; Shilane D; Boothroyd DB; Leong TK; Kazi DS; Chang TI; Hlatky MA
J Am Coll Cardiol; 2014 Jun; 63(21):2249-57. PubMed ID: 24703914
[TBL] [Abstract][Full Text] [Related]
18. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes.
Andersson C; Lyngbæk S; Nguyen CD; Nielsen M; Gislason GH; Køber L; Torp-Pedersen C
JAMA; 2012 Sep; 308(9):882-9. PubMed ID: 22948698
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
